MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
Phase 3 Recruiting
492 enrolled
Pre-malignant States to Hematologic Malignancies in Firefighters
Recruiting
300 enrolled
Phase II Study of Salvage Radiation Treatment After B-cell Maturation Antigen Chimeric Antigen Receptor T-cell Therapy for Relapsed Refractory Multiple Myeloma
Phase 2 Recruiting
30 enrolled
Long-term Evaluation and Follow-up Care of Patients Treated With Stem Cell Transplants
Recruiting
1,000 enrolled
Study to Assess Safety and Efficacy of HDP-101 in Chinese Patients With Relapsed or Refractory Multiple Myeloma
Phase 1 Recruiting
15 enrolled
Phase I/II Trial of Cord Blood-Derived NK Cells Genetically Engineered With NY-ESO-1 TCR/IL-15 Cell Receptor for Relapsed/Refractory Multiple Myeloma
Phase 1/2 Recruiting
44 enrolled
REALIZE
Phase 1 Recruiting
60 enrolled
Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care
Phase NA Recruiting
400 enrolled
A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
Phase 1 Recruiting
125 enrolled
Multimodal Telerehabilitation in Patients Undergoing CAR-T Cell Immunotherapy
Phase NA Recruiting
40 enrolled
A Phase 1 With Extension Cohort, Single Arm, Single Center, Open Label Trial of Belantamab Mafodotin for the Treatment of High-Risk Smoldering Multiple Myeloma
Phase 1 Recruiting
30 enrolled
EASE
Phase 2 Recruiting
100 enrolled
Elotuzumab + Iberdomide + Dexamethasone Post Ide-Cel in RRMM
Phase 1/2 Recruiting
49 enrolled
Elranatamab Post Cilta-cel in Patients With Clinical High Risk Relapsed Myeloma
Phase 2 Recruiting
39 enrolled
LIBERATE
Recruiting
2,500 enrolled
Subcutaneous Daratumumab Administration in the Thigh Vs Abdomen in Plasma Cell Disorders
Phase 1/2 Recruiting
30 enrolled
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Recruiting
15,000 enrolled
Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Platform Trial (RATIONAL-PT)
Phase 2/3 Recruiting
900 enrolled
Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Dosing Immunoglobulin (Dose Ig)
Phase 2/3 Recruiting
900 enrolled
Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Starting Immunoglobulin (Start Ig)
Phase 2/3 Recruiting
900 enrolled
Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Immunoglobulin Stopping or Extension (Stop Ig)
Phase 2/3 Recruiting
900 enrolled
HEME Home Transfusion Program
Phase NA Recruiting
700 enrolled
Impact of Recombinant Human Interleukin-7 (CYT107) on Tumor Clearance and Immune Reconstitution in Multiple Myeloma Patients After Autologous Hematopoietic Cell Transplant
Phase 1 Recruiting
30 enrolled
A Phase II Study of Siltuximab for CRS/ICANs After CAR-T in Multiple Myeloma
Phase 2 Recruiting
20 enrolled
MYRACLE
Recruiting
1,400 enrolled
A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties
Phase NA Recruiting
60 enrolled
3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer
Recruiting
Registry of Older Patients With Cancer
Recruiting
3,000 enrolled
BAH2573
Phase 1/2 Recruiting
60 enrolled
High Dose Ascorbic Acid (HDAA) in Patients With Plasma Cell Disorders
Phase 1 Recruiting
18 enrolled